Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 3/20 | 0.35 |
| ▸ | APP | P05067 | 3/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13380677 | 0.94 | TSHR (0.43) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL17933164 | 0.92 | RELA (0.49) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL12292313 | 0.91 | RELA (0.46) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL13380678 | 0.90 | PTGS1 (0.38) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL17933167 | 0.89 | RELA (0.41) | RELAALDH1A1GLAMAPTSMN1; SMN2 | |
| SCHEMBL13358339 | 0.88 | RELA (0.47) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL13358676 | 0.88 | RELA (0.47) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL13358424 | 0.88 | RELA (0.47) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL13358645 | 0.88 | RELA (0.47) | CYP1A2RELAALDH1A1GLAMAPT | |
| SCHEMBL13358266 | 0.88 | RELA (0.47) | CYP1A2RELAALDH1A1GLAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8476474-B2 | Asymmetric styryl derivatives and organic light emitting diode prepared using the same | DOOSAN CORPORATION (KR) | 2013-07-02 | — | — | US | disclosed |
| US-8476474-B2 | Asymmetric styryl derivatives and organic light emitting diode prepared using the same | DOOSAN CORPORATION (KR) | 2013-07-02 | — | — | US | disclosed |
| US-20100081846-A1 | ASYMMETRIC STYRYL DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE PREPARED USING THE SAME | DOOSAN CORPORATION (KR) | 2010-04-01 | — | — | US | disclosed |
| US-20100081846-A1 | ASYMMETRIC STYRYL DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE PREPARED USING THE SAME | DOOSAN CORPORATION (KR) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081846-A1 | ASYMMETRIC STYRYL DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE PREPARED USING THE SAME | ELOVL1, EML4, ACSL1 | CYP1A2 820/4885RELA 589/4885ALDH1A1 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.